EverPoint Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-325,000
Closed -$3.92M 348
2015
Q4
$3.92M Buy
+325,000
New +$3.92M 0.08% 256